Beatriz Paradela-Dobarro
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Beatriz
Contact Beatriz, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Correction to: Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling
Correction to: Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling Alfredo Redondo1, 2,3, Isabel Moscoso2,3, María Moure-Álvarez1, María Cebro-Márquez2, 1,2,3, Javier García-Seara1,2,3 & Ezequiel Álvarez ORCID: orcid.org/0000-0002-2381-84253,4 Journal of Molecular Medicine (2021)Cite this article The Original Article was published on 27 February 2021 Correction to: Journal of Molecular Medicine The original publication contains an error.
Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling
Abstract Post-infarction remodeling is a clinical problem with no curative treatment. Our objective was to search for new biomarkers of cardiac remodeling that have clinical value after ST-segment elevation myocardial infarction (STEMI). This pilot study enrolled 67 consecutive patients with de novo STEMI who underwent revascularization by primary angioplasty. Echocardiography studies of cardiac function were completed during the first 48 h post-STEMI and after 6 months of follow-up.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Beatriz
Contact Beatriz, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack